Sigma-Aldrich Declares Dividend of $.115 a Share Nov 15, 2007 Save for later NEW YORK (GenomeWeb News) - Sigma-Aldrich’s board of directors on Wednesday declared a quarterly cash dividend of $.115 per share. The dividend is payable on Dec. 14 to shareholders of record as of Nov. 30. Breaking News Genapsys Founders Lose Bid to Dismiss Bankruptcy Case Autism Spectrum Disorder Studies Uncover Additional Genetic Risk Variants QuidelOrtho Board Authorizes $300M Share Repurchase CorDx Gets CE-IVD Marks for Monkeypox Assays Personalis Adds Newly Issued Patent to Foresight Diagnostics Infringement Suit The Scan Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study. New Insights Into TP53-Driven Cancer Researchers examine in Nature how TP53 mutations arise and spark tumor development. Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer. Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing. What's Popular? Genapsys Founders Lose Bid to Dismiss Bankruptcy Case Cancer Centers Nudge Oncologists Toward DPYD Testing as PGx Supporters Push For Guidelines Change Premium Polygenic Risk Scores Can Differ for Same Disease in Individuals, Hampering Clinical Implementation Premium Sema4 Cuts 13 Percent of Workforce, Exits Somatic Tumor Testing as Founder Schadt Departs Premium Eurobio Scientific to Acquire GenDx for €135M in Cash
